ATDev
PrivateLast Round
Grant
Nov 6, 2025
Total Funding Raised
$3.61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ATDev operates in Healthcare & Life Sciences and is based in Orange, California. Its latest recorded funding round was a Grant round in November 2025.
ATDev is a health tech company that develops robotic mobility devices and a telehealth platform designed to assist with physical therapy and orthopedic rehabilitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATDev Comparables
Compare ATDev with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| H ROBOTICS INC | 86% | |
| MYOLYN, Inc. | 79% | |
| Motus Nova | 78% |
For institutional investors. Book with your work email.
ATDev Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2025 | ||||
| Grant | Nov 22, 2024 | ||||
| Accelerator | May 29, 2024 | ||||
| Seed | Dec 7, 2022 | ||||
| Grant | Sep 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ATDev Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| U.S. Department of Health and Human Services | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Berkeley SkyDeck | Seed |
| UpHonest Capital | Grant |
| ARPA-H | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 157% MoM.
- Aug 1, 2026
Grew 25% QoQ from 12 to 15 employees.
For institutional investors. Book with your work email.
ATDev Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ATDev's valuation, stock price, and market status.
Is ATDev a public or private company?
ATDev is a private company.
What is the current stock price of ATDev?
ATDev is a private company, so its shares have no public market price. Caplight tracks ATDev's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ATDev worth (valuation)?
Valuation information for ATDev is not publicly available.
Can I buy ATDev stock?
ATDev shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ATDev's last funding round?
ATDev's most recent funding round was Grant on November 6, 2025.
Who are the main investors in ATDev?
Key investors in ATDev include National Institute of Biomedical Imaging and Bioengineering, U.S. Department of Health and Human Services, MedTech Innovator, Big Red Ventures.
Will ATDev IPO soon?
No public IPO plans have been announced for ATDev.
How can I track ATDev secondary market activity?
Caplight tracks bids, offers, and trades in ATDev's shares on secondary markets.